HIFT for people with MRD for Mobility Limitation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Kansas, Lawrence, KS
Mobility Limitation+1 More
HIFT for people with MRD - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Investigators will examine the feasibility and health outcomes following a high-intensity functional training intervention for people with mobility-related disabilities. In addition to participant recruitment, attritions rates, and satisfaction, investigators will assess changes to both physical health outcomes (e.g., strength, body composition) and psychosocial outcomes (e.g., quality of life). The findings will provide evidence for the efficacy of HIFT to improve various health outcomes for a population that experiences health disparities in access to, and engagement in, community-based exercise.

Eligible Conditions

  • Mobility Limitation
  • Disabilities Physical

Treatment Effectiveness

Study Objectives

6 Primary · 10 Secondary · Reporting Duration: Change in baseline work capacity at weeks 10 and 12 of the intervention

Week 13
Skinfold
Week 13
Body Mass Index
Week 13
Perceived Quality of Life
Week 13
Flexibility
Week 13
Life Satisfaction
Week 13
Psychological Need Satisfaction
Week 13
Barriers to Health
Week 13
Perceived Functional Performance
Week 13
Self-determination
Week 13
Exercise Self-efficacy
Week 13
Sense of Community
Week 13
Shoulder Pain - wheelchair users only
Week 13
Sleep
Week 13
Strength
Week 12
Strength 5-repeition max
Week 10
Work Capacity
Observed each week of the 12-week intervention
Attendance
Week 9
Energy Expenditure

Trial Safety

Trial Design

1 Treatment Group

HIFT for People with MRD
1 of 1
Experimental Treatment

12 Total Participants · 1 Treatment Group

Primary Treatment: HIFT for people with MRD · No Placebo Group · N/A

HIFT for People with MRD
Other
Experimental Group · 1 Intervention: HIFT for people with MRD · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change in baseline work capacity at weeks 10 and 12 of the intervention
Closest Location: University of Kansas · Lawrence, KS
Photo of university of kansas medical center 1Photo of university of kansas medical center 2Photo of university of kansas medical center 3
2001First Recorded Clinical Trial
1 TrialsResearching Mobility Limitation
63 CompletedClinical Trials

Who is running the clinical trial?

University of KansasLead Sponsor
133 Previous Clinical Trials
323,191 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are not suffering from a significant health impairment that would contraindicate exercise.
You have a legal guardian.\n

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.